Sort
82,697 grants matching “vaccine development”
MAPs for Peds: Development of a Microarray Patch for Delivery of Long-Acting Antiretrovirals for Treatment of Pediatric HIV Infection
$833,526Darin Zehrung · Path · R61 · FY2020 · AI
Identification of the Initial Targets of Transmission
$833,492Thomas Hope · Northwestern University At Chicago · R37 · FY2017 · AI
Strategies for inducing bnAbs against QNES by infection with SHIVs
$833,435Shiu-Lok Hu · Univ Of Med/Dent Of Nj-Nj Medical School · P01 · FY2011 · AI
In vivo transformation of chimeric antigen receptor B cells for a functional cure of HIV
$833,420Michael R. Farzan · Boston Children'S Hospital · R01 · FY2025 · AI
Low-Cost Platform Technology for Rapid Isolation of Peripheral Blood Mononuclear Cells
$833,381Lotien Richard Huang · Cg Scientific, Inc. · R44 · FY2025 · GM
Prevention of Graft-Versus-Host-Disease in the Era of Adoptive Immunotherapy
$833,369Marie Bleakley · Fred Hutchinson Cancer Research Center · P01 · FY2018 · CA
Mosaic Display of Multivalent Tau and A-Beta peptides on Immunogenic SNAP Liposomes
$833,334Wei-Chiao Huang · Pop Biotechnologies, Inc · R42 · FY2025 · AG
Development of a Sustained Release Injectable Formulation for Long-Term Delivery of ELQs
$833,189Michael Kevin Riscoe · Oregon Health & Science University · R01 · FY2019 · AI
Chemoprophylaxis and HIV-Host Interactions
$833,172Robert M. Grant · J. David Gladstone Institutes · R01 · FY2010 · AI
Blocking type I interferon signaling to reverse T cell exhaustion and control HIV-1 reservoirs
$833,168Lishan Su · University Of Maryland Baltimore · R01 · FY2021 · AI
SARS-CoV-2 and Social Determinants of Health Impact on Inflammation Associated Depression Risk (SSIDR)
$833,123Linda Y. Kim · Cedars-Sinai Medical Center · R01 · FY2024 · MH
Engineering sustainable squalene analogues for novel vaccine adjuvant emulsions
$833,113Christopher B Fox · Access To Advanced Health Institute · R01 · FY2021 · AI
EPITOPE BASED DNA VACCINES FOR AIDS THERAPY
$833,081Idm Pharma, Inc. · P01 · FY2000 · AI
A novel vaccine: botulinum neurotoxin subunit on a viral carrier.
$833,079Matthias Johannes Schnell · Molecular Targeting Technologies, Inc. · R42 · FY2014 · AI
Elucidating the role of TSR glycosylation in Plasmodium parasites
$833,059Kristian Edward Swearingen · Institute For Systems Biology · R01 · FY2023 · AI
Blocking granzyme-mediated immune suppression to enhance HIV vaccine efficacy
$833,010Stephen N. Waggoner · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · AI
Immune signatures of CMV disease risk after orthotopic liver transplant
$832,910Emily Ford · University Of Washington · R01 · FY2025 · AI
Genetics of Coxiella burnetii
$832,831Robert A Heinzen · Niaid Extramural Activities · Z01 · FY2007 · AI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax
$832,784Kenneth Mark Coggeshall · Oklahoma Medical Research Foundation · U19 · FY2020 · AI
Administrative Core
$832,784Kenneth Mark Coggeshall · Oklahoma Medical Research Foundation · U19 · FY2020 · AI
Manufacturing and Toxicology Studies of DNA and Protein Vaccines
$832,766Gary R Ostroff · Univ Of Massachusetts Med Sch Worcester · U19 · FY2011 · AI
Novel nanobodies to prevent and treat SARS-CoV-2 and other pathogenic human coronaviruses
$832,650Lanying Du · New York Blood Center · R01 · FY2020 · AI
Immunologic Correlates of Immunization for Cancer
$832,603University Of Washington · U54 · FY2005 · CA
Statistical Issues in AIDS Research
$832,564James P Hughes · University Of Washington · R37 · FY2024 · AI
India International Center for Excellence in Research
$832,521Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI